Phase II trial of echinomycin in advanced hormone-resistant prostate cancer. An Illinois Cancer Council study.
Shevrin
D H
DH
Evanston Hospital, IL.
Lad
T E
TE
Guinan
P
P
Kilton
L J
LJ
Greenburg
A
A
Johnson
P
P
Blough
R R
RR
Hoyer
H
H
D000368:Aged; D004351:Drug Resistance; D004448:Echinomycin / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use*; D006728:Hormones / Q000627:therapeutic use; D006801:Humans; D007275:Injections, Intravenous; D008297:Male; D008875:Middle Aged; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000401:mortality; D015996:Survival Rate
D006728:Hormones; D004448:Echinomycin